Valganciclovir Powder, For Solution
Product Images NDC 31722-837

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 31722-837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber-logo (Camber Logo)

FDA Label Image

Valganciclovir-carton-label (Valganciclovir Carton Label)

Packaging label for Valganciclovir for Oral Solution 50 mg/mL, a powder for solution, orally administered, manufactured by Camber Pharmaceuticals, Inc. The label displays the NDC 31722-837-10 and container size 100 mL (3.4 fl oz). Instructions for pharmacists and storage details are included, along with dosage strength and preparation information.*

FDA Label Image

Valganciclovir-cntr-label (Valganciclovir Cntr Label)

Label for VALGANCICLOVIR 50 mg/mL oral solution powder for reconstitution by Camber Pharmaceuticals, Inc. The label includes preparation instructions, storage conditions, volume (100 mL), and manufacturer details. It states the product is prescription-only and includes a barcode with the NDC 31722-837-10.*

FDA Label Image

Valganciclovirformula (Valganciclovirformula)

An illustration showing two medical formulas: the Mosteller Body Surface Area (BSA) calculation formula and the Schwartz Creatinine Clearance formula. These formulas include variables such as height, weight, serum creatinine, and a constant k.*

FDA Label Image

Valganciclovirinstrucfigure1 (Valganciclovirinstrucfigure1)

An assembly diagram showing components of an oral dispenser system for a medication bottle. It labels the bottle with a child-resistant cap and a bottle adapter, and separately illustrates the oral dispenser's plunger, barrel with measurement markings, and tip.*

FDA Label Image

Valganciclovirinstrucstep1 (Valganciclovirinstrucstep1)

An instructional illustration showing a hand holding a bottle, demonstrating the action of shaking the bottle well. The text 'Shake well' is printed next to the bottle with arrows indicating the shaking motion.*

FDA Label Image

Valganciclovirinstrucstep10a (Valganciclovirinstrucstep10a)

An instructional illustration showing two syringes being filled with drops of liquid from a faucet or tap. The image likely indicates a dosing or preparation step involving liquid measurement.*

FDA Label Image

Valganciclovirinstrucstep10b (Valganciclovirinstrucstep10b)

An illustration of a syringe with measurement markings along the barrel and a plunger at the top. The syringe is empty and unfilled, shown in a simple black-and-white line drawing.*

FDA Label Image

Valganciclovirinstrucstep2 (Valganciclovirinstrucstep2)

An instructional illustration showing a bottle with a cap and an arrow indicating to turn the cap counterclockwise to open. The image likely demonstrates how to open the VALGANCICLOVIR oral powder for solution bottle.*

FDA Label Image

Valganciclovirinstrucstep3 (Valganciclovirinstrucstep3)

An illustration showing a dosage indicator for measuring liquid volume in milliliters (mL), likely part of an oral administration device such as a dosing syringe used with VALGANCICLOVIR powder for solution.*

FDA Label Image

Valganciclovirinstrucstep4 (Valganciclovirinstrucstep4)

An instructional illustration showing a hand pressing down on the top of a syringe or dropper device. The image appears to demonstrate administering or dispensing liquid medication, likely relevant to use or preparation instructions for an oral solution powder product.*

FDA Label Image

Valganciclovirinstrucstep5 (Valganciclovirinstrucstep5)

An instructional diagram showing a hand attaching a bottle adapter to the opening of a bottle. The diagram is labeled to indicate the 'Bottle adapter opening,' demonstrating the proper method for connecting the adapter to the bottle.*

FDA Label Image

Valganciclovirinstrucstep6 (Valganciclovirinstrucstep6)

An instructional illustration showing how to prepare oral valganiclovir hydrochloride powder for solution. The image depicts a hand holding a vial inverted and drawing liquid into a syringe, alongside a close-up of the syringe with measurement markings for accurate dosing.*

FDA Label Image

Valganciclovirinstrucstep7 (Valganciclovirinstrucstep7)

An instructional diagram showing a hand pulling upward on a syringe connected to a bottle, demonstrating the process of drawing powder for solution from the vial. The image relates to the preparation of oral powder for solution dosage form.*

FDA Label Image

Valganciclovirinstrucstep8 (Valganciclovirinstrucstep8)

An instructional illustration showing a person administering oral medication using an oral syringe aimed at the mouth. The image emphasizes correct positioning for oral drug delivery.*

FDA Label Image

Valganciclovirinstrucstep9 (Valganciclovirinstrucstep9)

An instructional illustration showing how to open a bottle by twisting off the cap. The image features a bottle with a cap and a curved arrow indicating the direction to turn the cap for removal.*

FDA Label Image

Valganciclovirstructure (Valganciclovirstructure)

Chemical structure diagram of valganciclovir hydrochloride, illustrating the molecular arrangement of atoms and bonds for this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.